Description
PP-121 an inhibitor of p110α PI3K, DNA-PK, mTORC1/2, Abl, Hck, Src, VEGFR2, and PDGFR that exhibits anticancer activity by inhibiting cellular proliferation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
PP-121 an inhibitor of p110α PI3K, DNA-PK, mTORC1/2, Abl, Hck, Src, VEGFR2, and PDGFR that exhibits anticancer activity by inhibiting cellular proliferation.
| Cas No. | 1092788-83-4 |
|---|---|
| Purity | ≥98% |
| Formula | C17H17N7 |
| Formula Wt. | 319.36 |
| IUPAC Name | 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[3,4-d]pyrimidin-4-amine |
| Solubility | DMSO 64 mg/mL (200.4 mM) Ethanol 2 mg/mL (6.26 mM) Water Insoluble |
| Appearance | White Crystal Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Apsel B, Blair JA, Gonzalez B, et al. Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat Chem Biol. 2008 Nov;4(11):691-9. PMID: 18849971.
Piperazine; 5-HT1 agonist, 5-HT2/3 and α2-adre...
Imidazole; 14-α demethylase, H+/K+ ATPase, Na+...
ACE inhibitor.
Taxane found in species of Taxus; potential mic...
Diterpene found in coffee beans.
T-type Ca2+ and voltage-gated Na+ channel block...
principal metabolic product of COX-2
Oxidative phosphorylation inhibitor.
Macrolide; ET antagonist, proteasome inhibitor....
Synthetic derivative of glycyrrhizin; connexin ...
Cyclosporin metabolite; formyl peptide inhibito...
5-HT2 antagonist, SERT and NET inhibitor, hERG ...
Nitroimidazole, binds DNA; nucleic acid synthes...
MEK1/2 and ERK inhibitor.
Raf inhibitor.
Camptothecin derivative; topoisomerase I inhibi...
Docetaxel impurity
Endogenous peptide, involved in stress signalin...
PLK4 inhibitor.
V600E B-Raf inhibitor.